Specialists highlight the importance of screening for cancer cure.

February 4, World Day against cancer.

-el Hospital Provincial de Castellón attended last year 1300 new cases

Castellón, February 2012.- specialists of the Oncology Institute of the Provincial Hospital consortium of Castellón have underlined the importance of prevention and early detection on the occasion of world day against cancer disease control.

Also, experts advise healthy lifestyle habits and follow a balanced diet in which abundant fruits and vegetables, practicing physical exercise regularly and avoid consumption of alcohol and tobacco.

The director of the Oncology Institute, Carlos Ferrer, said that while the incidence of cancer is increasing, it has also increased the survival of patients, since due to the continuous improvement of the means of diagnosis and treatment the disease ceases to be threatening to become a chronic condition ”.

Physicians in the area of medical oncology of the Consortium received last year a total of 1.294 new cases of cancer. Breast, colon, lung and prostate are, in this order, most treated tumors.

New techniques and treatments

Ferrer stressed the commitment of the consortium by the introduction of new techniques as well as the improvement of treatment and diagnostic systems. As stated, to the improvement of therapeutic media joins the fact that medicine is becoming more personalized and diagnostic tests that allow to select the most appropriate for each patient treatments, have emerged in recent years which improves survival ”.

The innovative techniques applied in the Castellon Centre include metabolic therapy, brachytherapy prostate and gynecological, as well as chemotherapy or radiotherapy supplied at the time of surgery.

Avant-garde Center

The Consortium hospital Provincial de Castellón is – according to their palabras-a the forefront of research in the area of the radiation oncology with participation in projects that allow the development of technical pioneer internationally to improve the treatment of cancer patients.

In this regard, referred to the recent establishment of a computer tool for simulation and planning for the treatment of intraoperative radiotherapy to set the most appropriate protocol for each pathology.

This tool – alone in the world – allow the virtual implementation of interventions that will be subsequently applied to patients with the most appropriate radiation dose, which will make it possible to increase the number of interventions and improve the therapeutic index.

On the other hand, the ethical Committee of clinical investigation (CEIC) of Consortium has been validated since its commissioning numerous clinical trials and research projects of treatments that allow patients to benefit from the latest advances.